TrialClinical and vaccine immunology : CVI2007

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents.

Dominique Boutriau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.